Course Description
Course Fee: $255
CE: 2.0 credits
This three-module course presented by Dr. James Greenblatt presents a novel paradigm for the prevention of Alzheimer’s, as well as general cognitive decline. It examines the pathophysiology of neurodegenerative illness from a functional medicine and systems biology framework, focusing on biochemical abnormalities contributing to neuronal dysfunction that are modifiable at certain prodromal stages…and, accordingly, viable functional treatment targets. Research supporting the use
of low-dose lithium and other evidence-based nutritional interventions as part of a preventative approach will be objectively reviewed, and the mechanisms through which these interventions confer neuroprotection elucidated.
Finally, evidence-based recommendations for the use of low-dose lithium and other functional medicine treatments will be proffered, providing students with actionable information that can be incorporated into existing treatment protocols to maximize therapeutic – and cognitive – outcomes.
Learning Objectives
Upon completion of this course, students will be able to:
- Describe one way in which high homocysteine is related to risk for Alzheimer’s
- List three OPCs and describe how they may impact brain health
- Explain what each of the letters in the ZEEBRA model stands for, as an approach to treating Alzheimer’s and cognitive decline
Modules
Module 1
- An Overview of Neurodegenerative Illness
a. Epidemiology, presentation
b. Pathophysiology - The Search for A Cure
a. Investments, failures from Big Pharma - The Alzheimer’s prodrome: paradigm-altering implications
- Lithium
a. An essential, natural micronutrient
b. Neuroprotective properties
c. Research evidence: the Tap Water Studies
d. Elucidating dose: from nutritional to pharmaceutical
e. Research evidence: insights from Bipolar
f. Honing in on lithium’s utility for Alzheimer’s: when and how much matters!
g. Lithium as part of a preventative approach: hope on the horizon
h. Lithium mechanisms, effects on neurotransmission, inhibition of GSK-3, optimization of BDNF activity/expression
i. Lithium for irritability, agitation
j. Lithium for Parkinson’s - Elucidating a functional psychiatry model for Alzheimer’s prevention
Module 2
-
- Homocysteine: A Modifiable Alzheimer’s Risk Factor
a. International consensus on risk
b. Mechanisms; exploring the relationship between HCy and Vitamin B12 - Vitamin B9 (Folate)
a. Folic acid vs. folate vs. L-methylfolate
b. Folate risk deficiency factors
c. Genetic risk factors: MTHFR polymorphisms - Vitamin B12
a. B12 deficiency: illuminating physical and neurologic symptoms
b. B12 to mitigate high HCy
c. Mechanisms of neuroprotection; influences on neurotransmission
d. Risk factors for B12 deficiency - Vitamin B6 (pyridoxine)
a. An essential cofactor: B6 functions
b. Exploring B6 and cognitive decline: the research
c. Pyroluria (Overview, clinical implications, testing, treatment) - Vitamin B2 (riboflavin)
a. Overview, function
b. Associations with cognitive decline - Vitamin B3 (niacin)
a. Illuminating B3’s importance: the history of pellagra
b. Niacin therapy: applications across diagnoses
c. Formulations, roles, biologic activity
d. Effects on cellular energy production, neurotransmission
e. Evidence supporting B3/nicotinamide as a treatment for Alzheimer’s - Vitamin D
a. Categorization, functions
b. Role in neurotransmission
c. Homeostatic controls: vitamin D and serotonin synthesis/regulation
d. Vitamin D and gene expression
e. Hypovitaminosis D: A global phenomenon
– Contributing factors
– Establishing laboratory values for insufficiency, deficiency, sufficiency
– The importance of testing
– Diet and vitamin D
– Vitamin D, aging, and Alzheimer’s: the research
– Elucidating critical windows for prevention
– Magnesium and vitamin D activation
- Homocysteine: A Modifiable Alzheimer’s Risk Factor
Module 3
-
- Oligomeric Proanthocyanidins (OPCs)
a. Classification – phenols
b. Neuroprotective effects
– Enzyme modulation/reuptake
– Influences on neurotransmission
c. Illuminating potential health benefits + clinical applications
d. Mechanisms
e. OPCs for brain health, cognition: the research - N-Acetyl Cysteine (NAC)
a. Antioxidant mechanisms, activity
b. NAC and Alzheimer’s: research-supported connections
c. Potential mechanisms of neuroprotection - Curcumin
a. Classification, distribution, tradition of medicinal usage
b. Pharmacologic properties
c. Proposed antidepressant mechanisms
d. Documented neuroprotective mechanisms
e. Case studies
e. Experimental studies, clinical trials
f. Anti-inflammatory, antioxidant properties
g. Factors influencing bioavailability
h. Curcumin + vitamin D - Creatinine
a. Associations with dementia, Alzheimer’s - Chromium
a. Biologic roles, influences on energy balance and neurotransmission
b. Evidence of neuroprotection - Choline
a. Overview of biologic roles
b. Dietary intakes, implications for meeting bodily requirements
c. Mechanisms of neuroprotection
d. Research evidence supporting citicoline for attention, memory
e. Magnesium and citicoline - Carnitine
a. Overview of biologic role, significance
b. Effects on mitochondrial function, metabolism
c. Proposed neuroprotective mechanisms
d. Research supporting utility for neurocognitive disorders - Psychosocial Factors: Loneliness
a. A new era: COVID19
b. Cognitive and affective sequelae of prolonged loneliness, isolation
c. Loneliness and dementia: the research - Recapping the Functional Medicine Approach
a. Targeted interventions
b. Diet
c. Essential testing
d. Illuminating the THE ZEEBRA model
e. The shifts towards proactive medicine
- Oligomeric Proanthocyanidins (OPCs)
A Glimpse Into Alzheimer’s Disease
The global burden of Alzheimer’s Disease, neurodegenerative disorders, and cognitive decline is massive. Every 65 seconds, someone is diagnosed with Alzheimer’s Disease; it is the 6th leading cause of death nationwide, and the only one amongst the top ten for which there is no cure. Despite extensive research, traditional medicine and treatments have come up short from curing this terrible disease. Attempts to find a viable pharmaceutical cure have, thus far, failed, and the tolls borne by victims and family members alike remain incalculable.
Research has confirmed Alzheimer’s to have a substantial prodrome; the biologic processes underlying progressive cognitive decline may in fact commence decades before symptoms begin to manifest. The discovery of a lengthy prodrome in Alzheimer’s and other dementias is cause for hope. A prodrome represents a window of opportunity, a chance to steer neurologic aging towards health, and to modify certain etiologic factors while they remain modifiable. Such factors are tools that can be wielded to potentially significant effect in a functional medicine model centered upon prevention.
Accreditation Information
Please click to expand and view accreditation information.
• CE Information
The CE Company is approved by the American Psychological Association to sponsor continuing education for psychologists. The CE Company maintains responsibility for this program and its content.
Course Level: Introductory
CE Instructions
This online program provides CE training and coursework. Accreditation requires the completion of a post-test. A passing grade of at least 75% must be met on this test in order to obtain certification. Instructions for certification will be provided upon completing the course in full.
Instructor Bio
A pioneer in the field of integrative medicine, James M. Greenblatt, MD, has treated patients since 1988. After receiving his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School. He currently serves as the Chief Medical Officer at Walden Behavioral Care in Waltham, MA, and serves as an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth College Geisel School of Medicine. Dr. Greenblatt has lectured internationally on the scientific evidence for nutritional interventions in psychiatry and mental illness. He is the author of seven books, including Finally Focused: The Breakthrough Natural Treatment Plan for ADHD. He is the founder of Psychiatry Redefined, an educational platform offering continuing online education, programs, and fellowships on functional and nutritional psychiatry for mental illness.
Conflict of Interest
The course instructor, James Greenblatt, M.D., is a consultant for Pure Encapsulations and owner of Psychiatry Redefined. He is also a key opinion leader for Fullscript. No assistance or financial compensation of any kind was provided by any outside commercial interest or entity in the development or preparation of this course.
Other Educational Tools You May Like
Integrative Medicine for Alzheimer’s
Learn about the breakthrough natural treatment plan to prevent Alzheimer’s in this book by Dr. James Greenblatt.
Low-Dose Nutritional Lithium Course
Learn how to safely utilize low-dose nutritional lithium as treatment for a range of psychiatric and neurological disorders.
Nutritional Lithium: A Cinderella Story
Learn more about how the magical mineral lithium can transform lives and improve mental health in this book by Dr. James Greenblatt.
Irritability & Anger: A Lithium Deficiency Disorder?
Learn more about treating aggression and irritability with nutritional lithium in our FREE ebook.
Stay in the know.
Sign-up now for updates, news and exclusive offers! Let’s redefine mental wellness together.
By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.
